These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8370476)

  • 1. Somatostatin analog lanreotide inhibits myocyte replication and several growth factors in allograft arteriosclerosis.
    Häyry P; Räisänen A; Ustinov J; Mennander A; Paavonen T
    FASEB J; 1993 Aug; 7(11):1055-60. PubMed ID: 8370476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic rejection in the rat aortic allograft. V. Mechanism of the angiopeptin (BIM23014C) effect on the generation of allograft arteriosclerosis.
    Mennander A; Räisänen A; Paavonen T; Häyry P
    Transplantation; 1993 Jan; 55(1):124-8. PubMed ID: 8420036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic rejection in rat aortic allograft: mechanism of angiopeptin (BIM 23014C) inhibition on vascular smooth muscle cell proliferation in chronic rejection.
    Räisänen-Sokolowski A; Mennander A; Ustinov J; Paavonen T; Häyry P
    Transplant Proc; 1993 Feb; 25(1 Pt 2):944-5. PubMed ID: 8095115
    [No Abstract]   [Full Text] [Related]  

  • 4. Blockade of growth factor synthesis and growth factor action: two possible sites of interference in allograft vessel disease and coronary bypass or balloon injury.
    Häyry P; Aavik E; Myllärniemi M
    Metabolism; 1996 Aug; 45(8 Suppl 1):101-3. PubMed ID: 8769397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triple drug immunosuppression significantly reduces aortic allograft arteriosclerosis in the rat.
    Lemström KB; Räisänen-Sokolowski AK; Häyry PJ; Koskinen PK
    Arterioscler Thromb Vasc Biol; 1996 Apr; 16(4):553-64. PubMed ID: 8624778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the rat.
    Lemström KB; Bruning JH; Bruggeman CA; Koskinen PK; Aho PT; Yilmaz S; Lautenschlager IT; Häyry PJ
    Circulation; 1994 Oct; 90(4):1969-78. PubMed ID: 7923687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial inhibition of allograft arteriosclerosis (chronic rejection) by 15-deoxyspergualin.
    Räisänen-Sokolowski A; Yilmaz S; Tufveson G; Häyry P
    Transplantation; 1994 Jun; 57(12):1772-7. PubMed ID: 8016883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus infection enhances mRNA expression of platelet-derived growth factor-BB and transforming growth factor-beta 1 in rat aortic allografts. Possible mechanism for cytomegalovirus-enhanced graft arteriosclerosis.
    Lemström KB; Aho PT; Bruggeman CA; Häyry PJ
    Arterioscler Thromb; 1994 Dec; 14(12):2043-52. PubMed ID: 7981194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of thromboxane in the generation of allograft arteriosclerosis in chronic rejection.
    Häyry P; Mennander A; Paavonen T; Räisänen A; Ustinov J
    Transplant Proc; 1993 Feb; 25(1 Pt 1):603-4. PubMed ID: 8438433
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic rejection in rat aortic allografts. IV. Effect of hypercholesterolemia in allograft arteriosclerosis.
    Mennander A; Tikkanen MJ; Räisänen-Sokolowski A; Paavonen T; Ustinov J; Häyry P
    J Heart Lung Transplant; 1993; 12(1 Pt 1):123-31; discussion 131-2. PubMed ID: 8443189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards understanding the pathophysiology of chronic rejection.
    Häyry P; Mennander A; Yilmaz S; Ustinov J; Räisänen A; Miettinen A; Lautenschlager I; Lemström K; Bruggeman CA; Paavonen T
    Clin Investig; 1992 Sep; 70(9):780-90. PubMed ID: 1450632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis.
    Mennander A; Tiisala S; Halttunen J; Yilmaz S; Paavonen T; Häyry P
    Arterioscler Thromb; 1991; 11(3):671-80. PubMed ID: 2029505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of AGI-1096, a novel antioxidant compound with anti-inflammatory and antiproliferative properties, on rodent allograft arteriosclerosis.
    Murata S; Sundell CL; Lijkwan MA; Balsam LB; Hammainen P; Coleman C; York C; Luchoomun J; Suen KL; Howard R; Somers PK; Morris RE; Robbins RC
    Transplantation; 2004 May; 77(10):1494-500. PubMed ID: 15239610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific effects of estrogen on growth factor and major histocompatibility complex class II antigen expression in rat aortic allograft.
    Saito S; Motomura N; Lou H; Ramwell PW; Foegh ML
    J Thorac Cardiovasc Surg; 1997 Nov; 114(5):803-9; discussion 809-10. PubMed ID: 9375610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of 15-deoxyspergualin in allograft arteriosclerosis in rat aortic transplants.
    Räisänen-Sokolowski A; Aho P; Tufveson G; Häyry P
    Transplant Proc; 1994 Dec; 26(6):3224. PubMed ID: 7998124
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of mycophenolate mofetil on allograft arteriosclerosis (chronic rejection).
    Räisänen-Sokolowski A; Myllärniemi M; Häyry P
    Transplant Proc; 1994 Dec; 26(6):3225. PubMed ID: 7998125
    [No Abstract]   [Full Text] [Related]  

  • 17. Intimal thickening and medial necrosis in allograft arteriosclerosis (chronic rejection) are independently regulated.
    Mennander A; Paavonen T; Häyry P
    Arterioscler Thromb; 1993 Jul; 13(7):1019-25. PubMed ID: 8318503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A vitamin D analog, MC1288, inhibits adventitial inflammation and suppresses intimal lesions in rat aortic allografts.
    Räisänen-Sokolowski AK; Pakkala IS; Samila SP; Binderup L; Häyry PJ; Pakkala ST
    Transplantation; 1997 Apr; 63(7):936-41. PubMed ID: 9112343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection.
    Lemström KB; Bruning JH; Bruggeman CA; Lautenschlager IT; Häyry PJ
    Am J Pathol; 1994 Jun; 144(6):1334-47. PubMed ID: 8203471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperlipidemia accelerates allograft arteriosclerosis (chronic rejection) in the rat.
    Räisänen-Sokolowski A; Tilly-Kiesi M; Ustinov J; Mennander A; Paavonen T; Tikkanen MJ; Häyry P
    Arterioscler Thromb; 1994 Dec; 14(12):2032-42. PubMed ID: 7981193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.